Scientific Program

  • Wednesday, October 26
  • Thursday, October 27
  • Friday, October 28

Friday, October 28

[SY11]
Harmonization and total laboratory automation in laboratory hematology era

Modern technological advancements have led to a tremendous progression in the field of medical sciences due to development in the field of hematology. Newer technology are constantly being introduced leading to precise diagnosis, reliable results, instruments and reagents. Advanced hematology instruments being developed today, now offer better and precise diagnosis at a lower turnaround time, with minimal wastage. The harmonization of diagnostics in hematology and laboratory implemented a total laboratory automation (TLA) system are issues whose complexity parallels that of laboratory hematology. Due to the many technological advancements occurred over the past few years, laboratory hematology has undergone a considerable transformation, which has also entailed the possibility to perform morphological analysis of peripheral blood smear through digital optical microscopy and generate many new blood cell population parameters, also including the so-called cell population data. With careful planning, a TLA system in hematology ara can effectively optimize laboratory processes and efficiency. The development of integrated laboratory reports, containing information gathered from basic hematological tests and more complex investigations shall be seen as an ambitious but profitable target.

Date & Time Oct. 28 (Fri.), TBD Room TBD Language Eng
Chair(s)
  1. TBD
Speaker(s)
  1. Harmonization of laboratory hematology: a long and winding journey
    Giuseppe Lippi, University Hospital of Verona, Italy
  2. Real world application of digital morphology analyzers in laboratory hematology
    Mina Hur, Konkuk University School of Medicine, Korea
  3. Advantages and limitations of total laboratory automation in hematology era
    Jaewoo Song, Yonsei University School of medicine, Korea

[SY12]
Education workshop for residents and new specialists in laboratory medicine

Date & Time Oct. 28 (Fri.), TBD Room TBD Language Eng
Chair(s)
  1. TBD
Speaker(s)
  1. Risk management in the clinical laboratory
    Sollip Kim, Inje University College of Medicine, Korea
  2. FISH testing in hematologic malignancies
    Hyun-Young Kim, Samsung Medical Center, Korea
  3. Laboratory diagnosis of bacterial infectious disease
    Dokyun Kim, Yonsei University College of Medicine, Korea
  4. Immunological diagnostic tests of COVID-19
    Sun Mi Cho, CHA University of College of Medicine, Korea

[PL03]
Artificial intelligence and infectious diseases: how much is important clinical microbiology?

Date & Time Oct. 28 (Fri.), TBD Room TBD Language Eng
Chair(s)
  1. TBD
Speaker(s)
  1. Artificial intelligence and infectious diseases: how much is important clinical microbiology?
    Maurizio Sanguinetti, Università Cattolica del S. Cuore, Italy

[KS04]
TBD

Date & Time Oct. 28 (Fri.), TBD Room TBD Language Eng
Chair(s)
  1. TBD
Speaker(s)
  1. Diagnostic and clinical implications of clonal hematopoiesis
    Lukasz Pawel Gondek, Johns Hopkins University School of Medicine, USA

[SY13]
Update on immunohematological testing

With the advances of new treatments, updates on immunohematological testing are required. In this session, some tests, which have recently become an issue, will be presented.

Date & Time Oct. 28 (Fri.), TBD Room TBD Language Eng
Chair(s)
  1. TBD
Speaker(s)
  1. Production of reagent red blood cells (RBCs) differentiated from stem cells
    Juhye Roh, Hallym University College of Medicine, Korea
  2. Use of next generation sequencing for blood group genotyping
    Yeongbin Kim, Korean Red Cross, Korea
  3. Updates in ABO antibody testing for ABO-incompatible transplantation
    Dae-Hyun Ko, University of Ulsan College of Medicine, Korea

[SY14]
COVID-19 Immunology

A pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is ongoing and a global challenge. The introduction of a COVID-19 vaccine has proven to be very effective in reducing infection-related mortality. Several vaccines have been developed that provide protection against COVID-19 by generating an immune response to the spike antigen of SARS-CoV-2. Vaccine-induced neutralizing antibodies are key to fighting COVID-19 pandemic. However, the continued emergence of highly contagious variants with mutations in the spike protein raises concerns about possible diminished vaccine effectiveness. In this session, we aimed to discuss the humoral and cellular immune responses after vaccination.

Date & Time Oct. 28 (Fri.), TBD Room TBD Language Eng
Chair(s)
  1. TBD
Speaker(s)
  1. Neutralizing antibodies for SARS-CoV-2 variants
    Laurent Rénia, Nanyang Technological University, Singapore
  2. Humoral response to SARS-CoV-2 vaccines
    Hyun-Woo Choi, Chonnam National University College of Medicine, Korea
  3. Assessment of T-cell responses against SARS-CoV-2 S peptides
    Hae In Bang, Soonchunhyang University College of Medicine, Korea

[SY15]
Management of special laboratory

The ‘Laboratory management committee’ will introduce the total management of special laboratories such as a ‘Mass spectrometry laboratory’, ‘Mycobacteriology laboratory’, and ‘Genomics laboratory’.

Date & Time Oct. 28 (Fri.), TBD Room TBD Language Eng
Chair(s)
  1. TBD
Speaker(s)
  1. Management of mass spectrometry laboratory
    Sung-Eun Cho, Green Cross Laboratories (GCLabs), Korea
  2. Management of mycobacteriology laboatory
    Young Jin Kim, Kyung Hee University College of Medicine, Korea
  3. Management of genomics laboratory
    Myungshin Kim, The Catholic University of Korea College of Medicine, Korea

[SY16]
MFDS-KSLM Joint Session
Performance Evaluation and Follow up for IVD in Pandemic

Accurate evaluation and reporting of hazards after authorization are very important for health and safety in order to increase the utilization of diagnostic tests, which have attracted attention due to the global pandemic of COVID-19. The External Cooperation Committee prepared a joint session in which MFDS, IVD manufacturer, and laboratory medicine experts discuss the evaluation and follow-up of medical IVD.

Date & Time Oct. 28 (Fri.), TBD Room TBD Language Kor
Chair(s)
  1. TBD
Speaker(s)
  1. Design for analytical and clinical performance of IVD for infectious disease diagnosis
    TBD
  2. Pre and post management of IVD
    TBD
  3. Strategic preparation of class 3 In-vitro diagnostic medical device re-evaluation: IVD company perspective
    TBD
  4. Proposal of network configuration for infectious disease (in vitro device) assessment
    Sung Jin Jo, The Catholic University of Korea College of Medicine, Korea

[SY17]
Infection control in the era of COVID-19 pandemic

The COVID-19 pandemic is having a profound impact on the epidemiology and control of other infectious diseases. Healthcare-associated infections, which were the main targets of traditional infection control, escape the control plan and spread as infection control resources are concentrated on COVID 19 or the twindemic of COVID-19 and other infectious diseases could cause serious adverse effect on healthcare system. In this session, the impact of the COVID-19 pandemic on respiratory virus infections, tuberculosis, CDI, etc., and ways to build better infection control after COVID-19 are presented.

Date & Time Oct. 28 (Fri.), TBD Room TBD Language Kor
Chair(s)
  1. TBD
Speaker(s)
  1. Effect of COVID-19 on epidemiology and infection control of respiratory viral diseases
    Heungsup Sung, University of Ulsan College of Medicine, Korea
  2. Epidemiology of tuberculosis in COVID-19 pandemic
    Young Ae Kang, Yonsei University College of Medicine, Korea
  3. Recent changes in the epidemiology of viral gastroenteritis
    Hyun Soo Kim, Hallym University College of Medicine, Korea
  4. Infection prevention and control in the post-COVID-19 era
    Hyukmin Lee, Yonsei University College of Medicine, Korea